Загрузка...
Updates on mechanism of action and clinical efficacy of risedronate in osteoporosis
Risedronate is a heterocyclic orally active aminobisphosphonate and it belongs to the bisphosphonate category: these drugs are powerful bone resorption inhibitors, thanks to their affinity for hydroxyapatite crystals at bone mineral matrix level and to their inhibiting effects on osteoclast activity...
Сохранить в:
| Опубликовано в: : | Clin Cases Miner Bone Metab |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
CIC Edizioni Internazionali
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4269145/ https://ncbi.nlm.nih.gov/pubmed/25568655 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|